SCHEMBL6786196

SCHEMBL6786196

Cn1ncc2nc3ccc(Cc4ccccc4CC#N)cc3c(Cl)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.35
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
RORC P51449 4/20 0.33
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
AGTR1 P30556 1/20 0.32
AGTR2 P50052 1/20 0.32
PDPK1 O15530 1/20 0.31
AKT1 P31749 1/20 0.31
SLC5A2 P31639 1/20 0.31
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782762 0.88 DPP4 (0.42) DPP4KDM4ECYP3A4CYP2C19HIF1A
SCHEMBL6781849 0.86 PDE2A (0.38) SLC6A2SLC6A4SLC6A3KDM4ECYP3A4
SCHEMBL6786104 0.83 CYP3A4 (0.46) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6784993 0.82 TUBB4A (0.41) KDM4EGAA
SCHEMBL6786756 0.81 KDM4E (0.41) DPP4KDM4ECYP3A4CYP2C19HIF1A
SCHEMBL6785647 0.80 NR1H2 (0.43) GAAMAPTPKMAGTR1AGTR2
SCHEMBL6781436 0.80 DPP4 (0.45) DPP4KDM4ECYP3A4CYP2C19HIF1A
SCHEMBL6784794 0.79 CYP3A4 (0.46) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6786326 0.78 PDE2A (0.42) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6781552 0.77 CYP3A4 (0.44) KDM4ECYP3A4CYP2C19HIF1ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG DPP4 3629/4885SLC6A2 3788/4885SLC6A4 3642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.